Clinical Trial Update: Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of Polyphenon E for patients at high risk of colorectal cancer, including advanced colorectal adenomas and colon cancer, was terminated with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Colon
• Colon Cancer
• Colorectal Adenoma
• Colorectal Cancer

Drugs mentioned

• Polyphenon E (sinecatechin)

Snippet

Sponsor: Mayo Clinic | Conditions: Advanced Colorectal Adenomas, Adenocarcinoma of the Colon | Phase 2 | Status: TERMINATED | Results posted: 2017-09-28